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Purpose To validate the predictive power for determining breast cancer risk 
of an automated breast density measurement system with full-fi  eld digital 
mammography (FFDM).
Materials and methods Two hundred cancers and 200 controls were imaged 
with FFDM. Density was measured separately on MLO and CC images using 
an integral automated volumetric breast density measurement system 
(Hologic, Quantra). For each cancer, the contralateral mammogram was 
used. Each cancer was matched to a control case by date of birth, age at 
examination and laterality of mammogram used for density determination. 
Breast density (percentage of fi  broglandular tissue) was analyzed by Quantra. 
Data were analyzed by conditional logistic regression to determine the eff  ect 
on breast cancer risk.
Results The percentage of breast density ranged from 6% to 63%. Density 
declined signifi  cantly with age (P <0.001). Overall, there was no signifi  cant 
association of density with risk of breast cancer (P  = 0.4). There was a 
suggestive increase in risk with dense volume higher than 35% (OR = 1.80, 
95% CI = 0.96 to 3.39, P = 0.07). There was signifi  cant heterogeneity by age 
in the eff  ect of density on risk (P = 0.04). In women aged <50, density was 
signifi  cantly associated with increased risk (P = 0.02), with odds ratios of 
6.06, 3.98 and 10.59 for density volumes of 15 to 24%, 25 to 34% and ≥35% 
respectively, relative to those with <15%. In women aged ≥50 years there 
was no association of density with risk (P = 0.5).
Conclusions Quantra automated volumetric breast density measurement is 
strongly associated with breast cancer risk in women aged under 50, but not 
in women aged ≥50 years or over.
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Introduction NICE guidelines recommend conventional ultrasound (CU) of 
the axilla as preliminary staging in patients with breast cancer. However, 
up to one-third of nodes showing normal morphology are metastatic 
on surgical histology [1]. Ultrasound elastography (UE) uses received 
radiofrequency data to produce an elastogram depicting tissue stiff  ness. UE 
has been researched in the breast but there are no published data regarding 
UE of the axilla.
Methods Fifty women attending the breast unit as symptomatic GP referrals 
with breast lesions sonographically suspicious of breast cancer underwent 
UE of the axilla simultaneously with routine CU examination. Elastograms 
were visually scored, strain measurements calculated and nodal perimeter 
and area measurements recorded. UE was compared with CU with histology 
as the reference standard.
Results Twenty-nine nodes were histologically normal, 21 were metastatic. 
Normal nodes were indistinguishable from surrounding tissue on UE. Using 
cut-off   points for biopsy selected for the study, sensitivity was 90% for UE 
visual scoring, 100% for strain scoring and 76% for CU. Specifi  cities were 86%, 
48% and 78% respectively. ROC analysis yielded AUC values of 0.9 for UE 
visual scoring, 0.86 for strain scoring and 0.82 for CU. There was no signifi  cant 
diff  erence between any area and perimeter measurements.
Conclusions UE can demonstrate axillary lymph nodes and diff  erentiate 
benign from malignant nodes. UE visual scoring shows greatest promise in 
improving yield without excessive benign biopsies.
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Introduction The purpose of surveillance mammography following primary 
breast cancer treatment is to detect subsequent cancers at the smallest 
size. We examined the prognostic eff  ect of size of ipsilateral breast tumour 
recurrence (IBTR) and metachronous contralateral breast cancer (MCBC) to 
assess potential benefi  t of surveillance mammography after breast cancer 
treatment.
Methods Second cancers (IBTR n = 1,174, MCBC n = 975) diagnosed 
between 1 January 1990 and 31 January 2007 from the West Midlands 
Cancer Intelligence Unit Breast Cancer Registry were analysed. Survival from 
diagnosis of second cancer was examined using Cox regression models. Risk 
factors included were prognostic factors of the primary tumour and size of 
the second tumour. Outcomes were time to all-cause death and to breast 
cancer death. Estimates are hazard ratios (HRs) and 95% confi  dence intervals.
Results There were 613 all-cause deaths and 422 breast cancer deaths 
after IBTR. For both outcomes, second cancers >2 cm had poorer prognosis 
compared with those <1 cm, HRs were 1.75 (1.29 to 1.37) and 1.99 (1.37 to 
2.89). In MCBC there were 358 all-cause deaths, HR 2.14 (1.49 to 3.06), and 23 
breast cancer deaths, HR 1.99 (1.38 to 2.83). © 2010 BioMed Central Ltd
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© 2010 BioMed Central LtdConclusions With either IBTR or MCBC the size of the second tumour is 
important, patients with cancers >2 cm in diameter being at a signifi  cantly 
greater risk of death. Lead-time bias from the mode of detection may be a 
factor in these results. The frequency of surveillance mammography should 
be considered for maximum benefi  t.
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Purpose To develop a 3.0 Tesla breast imaging protocol that combines high 
temporal and spatial resolution 3D MR sequences for quantitative time 
course and morphological analysis of breast lesions.
Materials and methods One hundred and sixty-fi  ve breast lesions classifi  ed 
by mammography or ultrasound as BIRADS 4 and 5 were included in this 
prospective IRB-approved study. The MRI protocol consisted of a coronal T2-
weighted TIRM and a coronal combined high temporal and spatial resolution 
T1-weighted sequence before and after application of a standard-dose 
Gd-DOTA (VIBE with a high temporal resolution of SI 1.7 mm isotropic; TA 
3.45 min for 17 measurements; FLASH with high spatial resolution of SI 1 mm 
isotropic; TA 2 min). Lesion size and morphology were assessed according to 
the BIRADS classifi  cation. ROIs for suspicious areas were manually drawn and 
evaluated for contrast-enhancement behavior by plotting intensity courses 
against time. Sensitivity and specifi  city with a 95% confi  dence interval and 
the negative predictive value (NPV) and positive predictive value (PPV) 
were calculated. Diagnostic accuracy was assessed. The histopathological 
diagnoses were used as the standard of reference.
Results All malignant breast lesions were identifi  ed correctly with a sensitivity 
of 100%, a specifi  city of 84% and a diagnostic accuracy of 95.7%. PPV was 
0.94 and a NPV 1. All seven false positive lesions were lesions with atypia.
Conclusions  The proposed combined 3 Tesla MR imaging protocol, 
comprising both high temporal and spatial resolution, enabled an accurate 
detection and assessment of breast lesions with high sensitivity and 
specifi  city reducing false positive breast biopsies
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Introduction To correlate pathological outcomes of MRI vacuum biopsies on 
MRI visible only breast lesions with lesion morphology, time-enhancement 
curves and clinical indications to determine the use of these as predictors 
for malignancy.
Methods A retrospective analysis of 277 patients referred for MRI-guided 
vacuum biopsies of impalpable breast lesions visible only on MRI was 
performed. All patients had a minimum follow-up period of 11 months. MRI 
biopsies were undertaken on a 1.5 T magnet using a minimum of 12 passes 
of vacuum-assisted biopsies. The pathological fi   ndings were correlated 
against BI-RADS appearances and time-enhancement characteristic of the 
lesions and against the clinical indications for MRI examination.
Results A total of 286 vacuum biopsies were undertaken. Eighty-one were 
malignant (28.3%), of which 72.8% are masses and 27.2% are nonmasses. Only 
two malignant lesions had a type 1 curve (2.5%), compared with malignant 
lesions with type 2 (54.3%) and type 3 curves (43.2%). Both malignant lesions 
with type 1 curve had a suspicious morphology. Nonmalignant lesions with 
type 3 enhancement included lymph nodes, fi  broadenomatoid hyperplasia, 
papillary lesions, fi  brocystic change and lobular neoplasia.
Conclusions Lesion morphology and time-enhancement curves are useful 
predictors of malignancy and can be used to develop an algorithm to help 
direct appropriate biopsy of MRI-detected lesions. We recommend that in 
the absence of suspicious morphology, only lesions with type 2 and type 3 
curves should be subjected to MRI-guided biopsy.
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Introduction Our screening programme has been fully digital since April 
2009 and utilises a combination of computed radiography (CR) (Fuji Profect) 
and three direct digital mammography (DDM) mammographic systems (Fuji 
Amulet, GE DS and GE Essential). This study compares the performance of 
our CR and DDM systems against fi  lm screen (FS) mammography in a real-life 
screening environment.
Methods Southern Derbyshire screening episodes between April 2007 and 
April 2010 were interrogated on NBSS using a Crystal report. Recall and 
cancer detection rates were collected according to mammography type. 
Data were analysed for signifi  cance using the chi-squared test.
Results A total of 66,989 screening episodes were recorded, 22,039 FS (recall 
rate 3.23%, cancer detection 8.08/1,000), 30,739 CR (recall rate 2.73%, cancer 
detection 7.87/1,000) and 14,157 DDM (recall rate 3.87%, cancer detection 
9.89/1,000). Recall rates compared with FS were statistically signifi  cantly 
diff  erent for CR (P = 0.0007) and DDM (P = 0.0016). Cancer detection rates 
compared with FS mammography were not signifi  cantly diff  erent for either 
CR (P = 0.833) or DDM (P = 0.081), although there was a signifi  cant diff  erence 
found between CR and DDM (P = 0.035).
Conclusions DDM in our programme has detected an increased number of 
cancers but at an increased recall rate. CR has detected a similar number of 
cancers as FS mammography at a lower recall rate and the study supports 
the use of CR in our programme. As an interim measure in changing to a fully 
DDM service it has allowed us to spread costs whilst adopting a single digital 
workfl  ow, which is effi   cient and safe for our clients.
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Introduction As a part of a retrospective study of computer-aided detection 
in breast cancer screening, we recorded the percentage of the breast density 
on a visual analogue scale on 4,866 routine screening mammograms taken in 
1996 as part of the North East of Scotland Breast Screening Service. In these 
women, 284 breast cancers were diagnosed from the time of the original 
mammograms up until February 2010.
Methods The main goal was to evaluate breast density as a breast cancer risk 
factor by detection mode, histology and time since the original mammogram. 
The association of density with risk of breast cancer was assessed using 
logistic regression giving odds ratios per 10% increase in density, and by 
comparison of continuous mean densities between particular groups of 
cancers and those who did not develop breast cancer.
Results After adjusting for age, breast density was signifi  cantly associated 
with cancer in the fi  rst 6 years after the original mammogram (OR per 10% 
density = 1.08, 95% CI = 1.01 to 1.15, P = 0.03), but not with cancer more than 
6 years after the mammogram (OR = 1.01, 95% CI = 0.93 to 1.10, P = 0.8). 
There was a statistically signifi  cant association between histological type 
of tumour and breast density (P = 0.02). The mean densities for no cancer, 
invasive ductal carcinoma, DCIS and invasive lobular carcinoma were 32% 
(SD 23%), 33% (21%), 35% (26%) and 44% (24%), respectively. The eff  ect of 
density on risk varied signifi  cantly by detection mode (P = 0.02), with highest 
densities being observed in interval cancers arising more than 1 year after 
the mammogram (55% compared with 32% in those with no cancer).
Conclusions Breast density as measured by visual analogue assessment is 
strongly associated with late interval cancers and with lobular carcinoma. Its 
predictive value for risk, however, declines with time since its measurement.
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Introduction Flat epithelial atypia (FEA) is seen with increasing frequency 
following biopsy of calcifi  cation detected through screening. FEA is often 
associated with more signifi  cant lesions including atypical ductal hyperplasia 
and ductal carcinoma in situ (DCIS). It is postulated that FEA may even 
represent the earliest morphological manifestation of DCIS and a precursor 
to invasive carcinoma. However, the signifi  cance of pure FEA still remains 
unclear. We aim to review the radiological and pathological features of FEA 
and evaluate the signifi  cance of FEA on needle core biopsy.
Methods We performed a retrospective analysis of all needle core biopsies 
containing FEA in the pathology database from April 2008 to April 2010. 
For each case the following data were recorded: mammographic features, 
method of further sampling (mammotome or diagnostic surgical biopsy) 
and histology from needle core biopsy, mammotome biopsy and surgical 
biopsy.
Results There were 35 needle core biopsies that contained pure FEA, of which 
89% (31/35) were associated with mammographic calcifi  cation. Following 
initial core biopsy, 21 patients had further sampling with mammotome 
biopsy, 13 patients underwent diagnostic surgical biopsy and one patient 
was not suitable for further intervention. There was an upgrade to DCIS in 
18% (6/34) and invasive carcinoma in 3% (1/34).
Conclusions Pure FEA on core biopsy is upgraded to carcinoma in 21% (7/34) 
of cases on further sampling and it is vital that we do not underestimate the 
biological signifi  cance of FEA. Increasing the awareness of FEA is crucial to 
ensure consistent and appropriate patient management.
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Introduction In routine breast screening using 2D digital mammography 
(2DM), mediolateral-oblique (MLO) and craniocaudal (CC) views are 
performed to maximise cancer detection. Digital breast tomosynthesis 
(DBT) improves the visibility of lesions by eliminating the problem of 
superimposition of normal structures, and there is uncertainty regarding the 
need for two views. The purpose of this study is to compare the accuracy of 
two-view 2DM with one-view DBT.
Methods Five hundred and one cases were evaluated from the DBT trial 
dataset of clients recalled for further workup after their initial fi  lm-screen 
mammography. Bilateral two-view 2DM and DBT examination were 
performed in all study subjects. Mammography scores (1 to 5) based on 
RCR Breast Group criteria were recorded and an overall score for 2DM was 
established based on the highest value of MLO and CC scores. Unblinded 
interpretation of the 2DM followed by MLO-alone DBT was carried out. 
Statistical analysis was done using the receiver-operative characteristic 
(ROC).
Results  There were 111 (22.1%) cancers. The ROC area under the curve 
(AUC) for two views combined 2DM was 0.915 and for MLO-alone DBT was 
0.960 (diff  erence 0.045; P = 0.009). The distribution of M-scores against the 
histology-proven malignant lesions is presented in Table 1.
Conclusions In this series, one-view (MLO-alone) DBT had superior sensitivity 
compared with two-view 2DM.
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Purpose To assess the diagnostic performance of computer-aided detection 
(CAD) for full-fi   eld digital mammography (FFDM) correlated with breast 
density assessed by an automated breast density measurement system 
(Hologic, Quantra) in breast cancers and age-matched healthy controls.
Materials and methods Two hundred breast cancers imaged with FFDM 
and 200 age-matched healthy controls were evaluated retrospectively 
using CAD. A CAD mark was scored true-positive if it correctly indicated a 
malignant lesion. All other CAD marks were considered false. CAD sensitivity 
and specifi  city were calculated and correlated with mammographic breast 
density (%).
Results  CAD correctly identifi  ed 157 of the 200 cancers, a sensitivity of 
79%. Sensitivity was suggestively but nonsignifi  cantly lower with increased 
density (P = 0.09). In those cancer cases with density at or below the median 
of 20%, sensitivity was 82%, compared with 75% in those with density 
above the median. The presence of one or more false CAD prompts was 
suggestively but not signifi  cantly more likely in controls than cases (87% 
vs. 80%, P = 0.06). The number of false prompts was signifi  cantly higher in 
controls (average 3.6 vs. 2.6, P <0.001). False prompts were signifi  cantly less 
likely with higher density (P = 0.008). False prompts were present in 86% of 
cases and controls with density at or below the median, and in 81% of those 
with density above the median.
Conclusions Increased breast density is signifi  cantly associated with higher 
specifi  city of CAD, and there is suggestive evidence that it is also associated 
with lower sensitivity.
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Introduction There is debate about the role and optimal organisation of 
follow-up following treatment for primary breast cancer. We estimated 
using the best available evidence whether early detection by surveillance of 
ipsilateral breast tumour recurrence (IBTR) and metachronous contralateral 
breast cancer (MCBC) was cost-eff  ective.
Methods An economic model compared alternative surveillance strategies 
involving mammographic surveillance and/or clinical follow-up performed 
at diff  ering surveillance intervals. The model structure was based upon 
discussions with the clinical experts involved in the study, a survey of UK 
breast surgeons and radiologists, and the literature. Data to populate the 
model came from a series of systematic reviews and an analysis of the West 
Midlands Cancer Intelligence Unit Breast Cancer Registry. Results of the 
model were presented as incremental cost per QALYs – a measure of relative 
effi   ciency.
Results The surveillance strategy most likely to be cost-eff  ective was mammo-
graphic surveillance alone provided every 12 to 24 months. This result held 
for women who had previously received either breast-conserving surgery or 
mastectomy. Results were sensitive to primary tumour characteristics (size, 
Table 1 (abstract P3)
 MLO–CC   
Imaging combined  MLO-alone  Percentage
score 2DM,  n (%)  DBT, n (%)  diff  erence, Δ
M1 1 0  0
M2 0 0  0
M3  28 (25.2%)  18 (16.2%)  9%
M4  32 (28.8%)  26 (23.4%)  5.4%
M5  50 (45.0%)  67 (60.3%)  15.3%
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S3grade, nodal involvement) used to defi  ne the likelihoods of developing an 
IBTR or MCBC. More intensive follow-up of women with higher likelihood of 
developing IBTR or MCBC may be worthwhile.
Conclusions Our conclusions remain tentative due to the paucity of the 
underlying evidence base but suggest surveillance is likely to improve 
survival, with a strategy of mammography alone every 12 to 24 months 
appearing cost-eff  ective.
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Purpose Preoperative breast cancer sizing is required for surgical planning. 
Breast ultrasound is widely used but may not be accurate. Assisted freehand 
ultrasound (AFUSON) of the breast is a novel method of ultrasound scanning, 
combining semi-automated elasticity ultrasound with B-mode imaging. This 
pilot study investigates whether AFUSON sizing corresponds more closely 
with wide local excision tumour dimensions than with B-mode alone.
Methods Twenty-three patients with early breast cancer were recruited 
with ethical approval through the NHSBSP. B-mode ultrasound and 
AFUSON images were acquired in predefi  ned planes. Pathology slices were 
taken in the corresponding longitudinal plane and were digitally scanned. 
Assessment of tumour dimensions, area and contour were made on B-mode, 
AFUSON and histopathology scans. The fi  ndings were correlated.
Results Although there were signifi  cant limitations in this pilot study, the 
tumour dimension accuracy increased from 66% (B-mode alone) to 82% 
(AFUSON). Tumour area accuracy increased from 61% (B-mode alone) to 90% 
(AFUSON). Some AFUSON contour images showed a high visual correlation 
with the equivalent histopathology scans.
Conclusions This pilot study suggests that AFUSON may be useful in early 
breast cancer sizing. Further studies will be done to acquire more data and to 
address some of the shortfalls in the study.
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Introduction  Women over 70 have poorer breast cancer survival than 
younger women, and this may be due to late stage at presentation [1]. 
Promoting early presentation with symptoms in older women attending 
for their fi  nal round of breast screening may reduce stage at diagnosis cost-
eff  ectively, and is unlikely to lead to overdiagnosis. We tested the effi   cacy 
of the 10-minute radiographer-delivered Promoting Early Presentation (PEP) 
Intervention to promote early presentation by increasing breast cancer 
awareness in the NHS Breast Screening Programme.
Methods  We randomised 867 women attending their fi   nal round of 
screening to receive the PEP Intervention or usual care, measuring breast 
cancer awareness at baseline and 1 year. We systematically reviewed the 
evidence of eff  ectiveness of interventions to promote cancer awareness and 
early presentation.
Results At 1 year, the intervention increased the proportion breast cancer 
aware compared with usual care (24% vs. 4%; odds ratio = 15.2, 95% CI = 4.8 
to 47.8). The systematic review found one randomised trial of a one-to-one 
intervention that showed a much smaller eff  ect on breast cancer awareness.
Conclusions  The PEP Intervention is more eff   ective than any other 
intervention to promote breast cancer awareness. It will now be off  ered to 
all women attending for a fi  nal mammogram in three NHS breast screening 
services, to assess costs and feasibility and to measure its eff  ect on breast 
cancer awareness in routine clinical practice. If implemented across the 
whole Programme, the PEP Intervention has the potential to reduce 
avoidable deaths from delayed symptomatic presentation in older women.
Reference
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Introduction Velindre Cancer Centre (VCC), Cardiff   provides radiotherapy 
and oncology services to the population of 1.5 million across southeast 
Wales. Historically at Velindre, breast cancer patients are followed up for at 
least 10 years, with annual mammography underpinning the service. The 
optimal length for continued annual surveillance has been debated and 
reduction to 5 years follow-up suggested. Therefore, a retrospective audit 
of breast cancers diagnosed on follow-up mammograms was undertaken to 
support the proposed reduced length of mammographic follow-up.
Methods Using the RIS and HIS electronic databases, follow-up mammograms 
over a 3-year period from 1 June 2006 to 31 May 2009 were collected and 
their report codes checked. All mammogram reports are coded using the 
Breast Imaging Reporting and Data System (BI-RADS). All mammograms 
coded 3 and above were identifi  ed. Subsequent radiological and histological 
reports were reviewed to identify confi  rmed malignancies.
Results In this 3-year period, there were 6,294 follow-up mammogram 
examinations at VCC. Ninety-seven reports were coded 3 or above (1.5%). 
Fifty-six new malignancies were confi  rmed. Of these, 44 (79%) occurred more 
than 5 years from original diagnosis.
Conclusions The results do not support reducing the length of follow-up to 
5 years. Further analysis of original pathology will be undertaken to attempt to 
risk-stratify patients and thus allow tailored follow-up regimes to be developed.
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Introduction  With the introduction of digital breast screening across 
the UK, screeners need to learn how best to inspect these images. A key 
advantage over mammographic fi  lm is the facility to use workstation image 
manipulation tools.
Methods  Forty two-view FFDM screening cases, representing malignant, 
normal and benign appearances, were examined by 14 radiologists and 
advanced practitioners from two UK screening centres. For half the cases, the 
mammography workstation image manipulation tools could be employed; 
and for the other half these were not used. Participants classifi  ed each case 
and indicated whether an abnormality was present. Throughout the study, 
the participants visual search behaviour as well as their image manipulations 
were recorded.
Results Whether or not image manipulation tools were used made very little 
diff  erence to overall performance (t test, P >0.05) as confi  rmed by JAFROC 
analysis fi  gure-of-merit values of 0.816 and 0.838 (with and without tools, 
respectively); performance not using tools was better. However, using 
tools signifi  cantly increased inspection time (P <0.5) as well as participants’ 
confi   dence. Detailed examination of participants’ image inspection 
behaviour elicited that when imaging tools were used then they spent 17 
to 77% of their time manipulating the images; with the less experienced 
participants spending more time using such tools. Eye movement data 
demonstrated that when abnormalities were missed then this was typically 
due to search errors.
Conclusions For these cases, whilst using imaging tools was not necessary 
to identify abnormalities, their use improved confi   dence, especially in 
identifying normal appearances. With experience, less use of such tools was 
evident.
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Introduction ShearWave™ elastography (SWE) provides a quantitative 
measure  ment of tissue stiff   ness with high spatial resolution and may 
improve characterization of breast masses. The goal of this study was to 
evaluate the reproducibility of SWE and the impact of adding SWE features 
to the BI-RADS classifi  cation of breast masses from the fi  rst 1,000 cases in a 
prospective multicenter trial.
Methods SWE studies were performed on a prototype of the Aixplorer 
system (Supersonic Imagine, Aix-en-Provence, France). A subset of 192 breast 
lesions (42.71% malignant) was analyzed. Reproducibility of SWE images and 
measurements was assessed; logistic regression analysis was performed to 
predict the pathology fi  ndings. SWE features were added to the ultrasound 
BI-RADS to generate models that were challenged by comparing the areas 
under the ROC curves (Az), and the sensitivity and specifi  city scores.
Results In the preliminary analysis, intra-operator reproducibility of SWE size 
(R ≥0.93) and mean elasticity (R = 0.88) measurements were in near-perfect 
agreement. Using the best three-variable model (BIRADS + elasticity shape 
+ maximum elasticity), the Az increased from 0.77 to 0.93 and specifi  city 
increased from 61.8% to 87.3%, although sensitivity decreased from 92.7% 
to 87.8%. Adding more variables did not eff  ect further improvements.
Conclusions In this ongoing study, SWE provided reproducible information 
(elasticity values and SWE mapping) that improved the characterization 
of breast lesions. These features are directly linked to the characteristics of 
SWE: local quantifi  cation and millimeter resolution. Further evaluation of the 
study is in progress.
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To recognise the imaging of complications from Macrolane™ injection
SE McWilliams1, L Wilding2
1Guy’s and St Thomas’ NHS Trust, London, UK; 2West Middlesex University Hospital, 
London, UK
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Introduction Macrolane™ volume restoration factor (VRF) (Q-Med) is in vogue 
for use in breast augmentation. There is sparse literature on the imaging 
characteristics of complications resulting from Macrolane™ injection.
Methods This study describes the multimodality imaging of 12 patients 
from three centres who had breast complications as a result of Macrolane™ 
injection. The patients had all undergone Macrolane™ injection at varying 
intervals prior to presentation. Macrolane™ consists of non-animal 
stabilised hyaluronic acid (NASHA™) and is approved for nonsurgical breast 
augmentation. Treatment involves injection of up to 100 ml fl  uid, superfi  cial 
to the pectoral muscle and deep to the glandular breast disc, and is semi-
permanent, usually only lasting up to 1 year before a top-up injection is 
required.
Results Presenting symptoms included breast lumps, breast pain and axillary 
pain. The complications seen on imaging included abscess formation, in-
determinate masses, subpectoral collections and complex cystic collections. 
The fl  uid and indeterminate masses were not all resorbed in the timeframe 
expected of Macrolane™ and remained in situ in some cases for at least 
2 years.
Conclusions Macrolane™ injection is associated with long-term complica-
tions and creates diagnostic challenges on breast imaging that are only 
beginning to emerge in the breast clinics and that may warrant triple 
assessment.
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Purpose To determine texture features of IDC and invasive lobular carcinoma 
(ILC) of the breast on full-fi  eld digital mammography (FFDM). To evaluate the 
ability of texture analysis to diff  erentiate between those tumor types.
Materials and methods Fourteen IDC and nine ILC imaged with FFDM were 
included in this study. For each lesion the ROI was manually defi  ned covering 
the lesion and 1 cm normal-appearing breast tissue around the lesion. 
Texture features derived from the grey-level histogram, the co-occurrence 
matrix, the run-length matrix, the absolute gradient, the autoregressive 
model, and the wavelet transform were calculated for the ROIs. Fisher 
coeffi   cients were calculated to determine which texture features were best-
suited for distinguishing between IDC and ILC. Based on the combination 
of those fi  ve texture features with the highest Fisher coeffi   cients, lesion 
classifi  cation was performed, using linear discriminant analysis (LDA) and 
principal component analysis (PCA) classifi  ers, as well as a k-means clustering 
algorithm. Classifi  cation accuracy was used as the primary outcome measure.
Results Of the fi  ve texture features with the highest Fisher coeffi   cients, the 
top four were derived from the wavelet transform. Using LDA and PCA, 
classifi  cation accuracies of 82.6% (19 of 23 lesions) and 78.3% (18 of 23 
lesions) were achieved, respectively. k-means clustering also yielded a similar 
classifi  cation accuracy of 82.6% (19 of 23 lesions).
Conclusions Texture features, best suited for discrimination between ILC and 
IDC, are derived from the wavelet transform. Texture analysis of breast cancer 
cases imaged with FFDM allows a good degree of accuracy of discrimination 
between IDC and ILC.
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histopathological tumor types and appearances
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Purpose  To retrospectively evaluate the sensitivity of computer-aided 
detection (CAD) for full-fi  eld digital mammography (FFDM) in 360 breast 
cancers with regard to mammographic appearance and histopathological 
tumor type.
Materials and methods Three hundred and sixty breast cancers imaged with 
FFDM were evaluated retrospectively using CAD. A CAD mark was scored true 
positive (TP) if it correctly indicated a malignant lesion. All other CAD marks 
were considered false. Cancer cases were classifi  ed as microcalcifi  cations (64), 
masses (196), or both (100). Histopathological fi  ndings were classifi  ed as IDC, 
ILC, DCIS or other. Sensitivity values for CAD according to mammographic 
appearance and, histopathological fi  ndings were analyzed using chi-squared 
tests.
Results  A TP mark was observed on 319 out of the 360 cancers (89%). 
Calcifi  cations were signifi  cantly (P <0.001) more likely to be marked than 
masses, 163/164 (99%) compared with 244/296 (82%). The probability 
of a mass TP mark was signifi  cantly related to histological type (P <0.001), 
with sensitivity being greatest for IDC at 76% (167/221) compared with 
67% (38/57) for ILC, 31% (16/51) for DCIS and 74% (23/31) for other types. 
The probability of a calcifi  cation TP mark was also signifi  cantly related to 
histological type, with sensitivity being greatest for DCIS at 75% (38/51), 
compared with 43% (96/221) for IDC, 33% (19/57) for ILC and 32% (10/31) 
for other types.
Conclusions  CAD prompted the signifi   cant majority of radiological 
abnormalities related to cancers and was most accurate for detection of 
calcifi  cation and DCIS, less so for mass lesions and ILC.
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Introduction To investigate whether touch imprint cytology (TIC) of needle 
core biopsy (NCB) is as eff  ective as fi  ne needle aspiration cytology (FNAC) for 
providing same-day diagnosis of benign and malignant breast lesions at our 
one-stop symptomatic breast clinic.
Methods We prospectively studied 426 women with image-detected breast 
lesions who underwent FNAC and NCB with subsequent TIC. All of the FNAC 
and TIC samples were sent for immediate reporting. These were read by 
one of fi  ve consultant cytopathologists. The TIC results were subsequently 
compared with the defi  nitive histopathology from either the core biopsy or 
the fi  nal surgical specimen.
Results Complete data were present for all patients. TIC was compared with 
FNAC in providing an accurate and defi  nitive same-day diagnosis in lesions 
graded C2 (benign) and C5 (malignant). For FNAC, C2 = 75/426 and C5 = 
210/426 allowing 66.8% of women a defi  nite same-day diagnosis. For TIC, 
C2 = 92/426 and C5 = 223/426 allowing 73.8% of women a defi  nite same-day 
diagnosis. There were no false positive results.
Conclusions The accuracy of TIC is at least equivalent to FNAC when used 
as a stand-alone technique for defi  nitive same-day diagnosis from a single 
biopsy. We therefore conclude that FNAC is no longer necessary, thus saving 
a second invasive procedure.
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Introduction  Image degradation due to motion artefact in breast MRI 
represents a diagnostic challenge. Tumours are often detected manually 
by a radiologist or with computer-aided detection (CAD) systems, which 
utilise areas of enhancement that meet a predefi  ned threshold. The aim of 
this study was to test a new threshold-independent CAD algorithm and to 
correlate its fi  ndings to the conventional manual analysis.
Methods CAD was tested on retrospectively acquired MRIs of 14 patients 
with pathologically proven carcinomas. CAD results were obtained in a fully 
automated manner and the expert was blinded to the CAD fi  ndings. Noise 
artefacts were eliminated with the patient motion reduction algorithm 
and suspicious tissues were delineated using a novel all-timepoint-based, 
threshold-independent parametric map approach. The algorithm evaluates 
the shape of the curve as a whole and uses the noise integral to the image to 
discriminate malignant from benign tissues.
Results  All CAD-identifi   ed tumours and generated kinetic curves were 
comparable with those of the manual analysis. In particular, tumour 
conspicuity was enhanced in two cases where image degradation by motion 
artefacts made data interpretation challenging to conventional analysis. See 
Figure 1.
Conclusions  CAD results were favourably viewed by experts and 100% 
correlated to conventional manual tumour detection. In particular, CAD 
appears to increase tumour conspicuity in cases with motion artefacts. 
Prospective analysis is required to test this model further.
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Introduction Hybrid imaging, integrating anatomical computed tomography 
(CT) with functional single-photon emission computed tomography (SPECT), 
has emerged as a powerful diagnostic tool in breast cancer imaging. This dual 
modality increases the specifi  city of skeletal scintigraphy in detecting bony 
metastases and achieves accurate sentinal lymph node mapping, directly 
infl   uencing the surgical approach. For patients with high-grade breast 
cancer, hybrid SPECT/CT provides the opportunity for a ‘one-stop shop’ with 
important implications for patient care, cost-eff  ectiveness and follow-up.
Methods We included 50 women with >15 mm grade 2 or grade 3 invasive 
breast cancer attending our imaging department over 6 months. Each 
underwent SPECT/CT imaging protocol using a 16-slice Phillips Precedence. A 
questionnaire assessed type/number of imaging visits and perceived anxiety 
levels. Change to patient management, radiation dose and estimated costs 
were also collected from the trust patient and imaging information systems 
and multidisciplinary notes, to assess overall value.
Results One-third of patients underwent signifi  cant change in medical or 
surgical management based on hybrid imaging. Overall, >90% of patients 
surveyed reported higher satisfaction following a ‘one-stop’ visit. Cost and 
total radiation dose of combined imaging were more favourable than for 
single visits.
Conclusions Whilst hybrid SPECT/CT in breast imaging remains in its infancy, 
its potential to add value for the clinician and patient is clear. The positive 
advantages for patient management and convenience/cost suggested in our 
pilot study suggest it is likely to infl  uence future breast cancer management 
protocols.
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Comparison of 1.5T and 3T in assessment of suspicious breast lesions
SK Arcot Ragupathy1, T Gagliardi1, TW Redpath2, S Flynn1, B Jagpal2, JKP Begley2, 
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Introduction MRI at 3T has advantages of increased spatial and temporal 
resolution but with known transmit fi   eld inhomogeneity problems. The 
objective of this study is to compare the confi  dence in characterising the 
breast lesions in 1.5T and 3T MRI examinations performed and to compare 
the conspicuity of the lesions.
Materials and methods Patients referred for a diagnostic MRI examination 
as part of their clinical work-up for a suspicious lesion or for preoperative 
Figure 1 (abstract P15). Left: tumour visualisation with conventional analysis DCE-MRI. Middle: CAD curve shape map (red, wash-out; green, plateau; blue, 
persistent). Right: kinetic curve.
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was undertaken on a 1.5T GE CVi/NVi (Milwaukee, WI, USA) and a 3T Philips 
Achieva (Best, the Netherlands). T2W, dynamic T1W (voxel size 0.85 x 1.19 x 
2 mm – 1.5 T MRI, and 0.6 x 0.6 x 2 mm – 3T MRI) and high-resolution fat-
suppressed T1W postcontrast sequences (single-dose contrast) were carried 
out. The confi  dence level in morphology and contrast kinetics (three-point 
scale) and conspicuity for each lesion (fi  ve-point scale, –2 to +2) was assessed 
by a single observer (SKAR).
Results Seventeen patients were included in the study. Eleven patients had 
one or more lesions, giving 22 lesions. The confi  dence level in assessing 
morphology was high in 16/22 and 19/22 and in assessing contrast kinetics 
was high in 12/22 and 16/22 in 1.5T and 3T examinations, respectively. The 
mean and standard deviation of the conspicuity score are 1.09 ± 0.88 for 3T.
Conclusions The confi  dence in characterising and conspicuity of the breast 
lesions is improved and no lesions identifi  ed at 1.5T were missed at 3T MRI. 
3T MRI can be used safely in clinical practice.
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magnetic resonance imaging of the breast
N AlRashidi, T Gagliardi, T Ahearn, T Redpath, F Gilbert
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Introduction  In breast MRI, morphological and dynamic enhancement 
features determine whether a lesion is benign or malignant but specifi  city 
is low. Diff  usion-weighted magnetic resonance imaging (DW-MRI) measures 
microscopic motion of water and gives quantitative measurement known 
as the apparent diff  usion coeffi   cient (ADC). This study was conducted to 
determine whether the whole of the lesion should be included within the 
region of interest (ROI) or whether a small ROI would diff  erentiate benign 
from malignant disease.
Methods Fifteen female patients with 15 suspicious lesions were imaged on 
a 3T MRI machine (Philips HealthCare, Best, the Netherlands). DWI-MRI was 
performed with b-values of 0, 150, 800 s/mm2 using single-shot SE-EPI (TR/
TE = 9,543 ms/50 ms). The ROI of the lesion and of fi  broglandular tissue was 
used to calculate ADC values. Histology or follow-up data were available for 
all lesions.
Results The mean ADC value of malignant lesions (13) from two small ROIs 
was 0.954 ± 0.145 mm2/second and for benign (2) was 1.69 ± 0.17 mm2/
second (Figure 1a). The ADC values for the whole lesion were 1.027 ± 
0.23 mm2/second and 1.78 ± 0.293 mm2/second, respectively (Figure 1b).
Conclusions There is a signifi  cant diff  erence between ADC values from large 
and small ROIs (P <0.05), with small ROIs giving greater diff  erentiation. DWI is 
a promising technique to improve specifi  city of breast MRI.
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Introduction  Papillary lesions of the breast may be heterogeneous and 
associated with atypia or frank malignancy. Current practice is to perform 
wider sampling of lesions showing benign papilloma on core biopsy because 
of the risk of underestimation of disease. The literature, however, is unclear 
about the negative predictive value (NPV) of 14-gauge needle core biopsy 
for atypia or malignancy.
Methods A retrospective review of image-guided biopsies performed over 
an 11-year period from January 1999 to December 2009 was undertaken. 
We identifi   ed cases with a 14-gauge core biopsy diagnosis of benign 
papilloma. Patients with atypia or malignancy on core biopsy were excluded. 
The imaging features and number of core samples were documented. All 
patients subsequently underwent lesion excision.
Results Seventy-eight patients had a diagnosis of a benign papilloma on 
core biopsy. Subsequent excision was with vacuum-assisted biopsy in 48 and 
surgery in 30. Twenty-eight patients with microcalcifi  cation had a stereo-
tactic-guided biopsy. Fifty patients with a mass had ultrasound-guided 
biopsy. Atypical ductal hyperplasia was found in three out of 28 (11%) who 
had microcalcifi  cation (mean number of 10 cores) and one out of 50 (2%) 
with a mass (mean number of three cores). Seventy-four (95%) patients had 
a benign papilloma only.
Conclusions The NPV for atypia and malignancy of 14-gauge core biopsy of 
papillomas is 95% in this series. Underestimation of disease is more common in 
lesions presenting with microcalcifi  cation. The current practice of wider sampling 
of all papillary lesions diagnosed on 14-gauge core biopsy should continue.
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Figure 1 (abstract P19). Box plot of ADC values for benign, malignant and normal tissue using (a) two small ROIs and (b) a large ROI.
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Introduction  All breast cancer patients in our centre undergo ipsilateral 
axillary ultrasound, followed by fi   ne needle aspiration (FNA) where 
appropriate in line with NICE guidelines. We use two needle passes into a 
suspicious node, without suction. Improved preoperative detection of nodal 
metastasis allows patients improved triage to appropriate axillary surgery. 
We present our analysis of the impact of the second needle in our axillary 
FNA procedure.
Methods All breast cancer patients undergoing axillary FNA from April 2010 
to July 2010 were included, where possible. The fi  rst FNA was labelled ‘1’ and 
the second ‘2’. Individual and overall FNA results were compared with fi  nal 
surgical pathology, where available.
Results The study included 27 female patients. There was a diff  erence in 
the cytology grading (described LN0 to LN5) allocated between the fi  rst 
and second needle in fi  ve cases (19%). The second needle increased sample 
adequacy on three (11%) occasions. Of the 17 patients that had axillary 
surgery, three had no lymph node metastases and the preoperative FNA 
cytology was LN2. There were no false positive cytology results. Preoperative 
cytology was LN5 overall in 11/14 (79%) patients with nodal metastases, with 
LN5 obtained only in the second pass in 4/14 (29%) cases (fi  rst-pass results: 
LN2/LN2/LN0/LN0). No complications were reported.
Conclusions  A second needle pass into suspicious axillary lymph nodes 
in breast cancer patients has been validated by this study, increasing our 
preoperative rate of detection of lymph node metastases.
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Introduction  The aim of this study was to compare the results of fi  ne 
needle aspiration (FNAC, current practice) with imprint cytology (CIC) from 
ultrasound-guided cores taken in the one-stop clinic setting. CIC allows 
same-day results with one biopsy procedure. Literature suggests CIC provides 
a higher sensitivity/C5 rate, although there are few direct comparisons of CIC 
with FNAC.
Methods  From October 2009 to April 2010, wherever possible, CIC was 
performed in patients undergoing both ultrasound-guided FNAC and 
core biopsy. CIC slides were independently reported blind to FNA results. 
Results were compared with core biopsy histology and therapeutic excision 
histology, when available.
Results The cases included 90 female patients with 93 masses (54 malignant, 
39 benign masses based on fi  nal histology). In the malignant group the 
C5 rate was 61% (33/54) for FNAC, 83% (45/54) for CIC and 85% (46/54) for 
the combination of FNA and CIC. No cancers in this sample had an initially 
benign core result with malignant FNA or CIC result. In the benign group the 
C2 rate was 41% (16/39) for FNA, 69% (27/39) for CIC, and 64% (25/39) for the 
combination of FNA and CIC. There were no false positive C5 results. Imprints 
were easy to perform and there was no damage to the core biopsy material. 
Cytologists encountered no problems interpreting CIC.
Conclusions The use of CIC in ultrasound-guided core biopsies in place of 
conventional FNAC has been validated by this study. No signifi  cant obstacle 
to adopting core imprint cytology has been identifi  ed.
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Introduction NICE guidelines suggest that patients with lobular breast 
cancer should be off  ered an MRI scan to measure the tumour size and to 
exclude multifocality and contralateral tumours. The aim of this study was to 
ascertain the eff  ect of this guideline.
Methods This guideline was introduced in January 2009. Patients with 
lobular cancer were selected from before and after this date. Cases were 
reviewed and compared for type of surgery, positive resection margins and 
alteration in patient management. The number of additional targeted USS 
and biopsies was also recorded.
Results Sixty-nine patents were included in the study, of which 22 had 
preoperative MRI scans. There was no signifi  cant diff  erence in mastectomy 
rates (MRI = 45.5% vs. no MRI 57.5%, P = 0.44) and no signifi  cant diff  erence 
in positive margins following WLE (MRI 41% vs. no MRI 35%, P = 0.23). Of 
the 22 MRIs 11 additional fi  ndings were reported, six in the contralateral 
breast, leading to nine targeted USS and eight further core biopsies. Three 
of these core biopsies confi  rmed malignancy. Two MRI scans demonstrated 
multifocality and one diagnosed contralateral DCIS. Four patients’ 
management was altered due to the MRI result, one of these was due to an 
increase in size. There was one case of multifocality that was invisible on all 
imaging.
Conclusions This study has shown that the guideline for preoperative 
MRI scanning in lobular cancer will alter the surgical management in 
approximately 20% of patients. An additional 20% of patients will undergo 
additional imaging and biopsies that do not alter management.
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breast and axillary ultrasound for assessment of screen-detected cancers
IT Perera1, LS Wilkinson2
1Guy’s and St Thomas’ Hospitals NHS Trust, London, UK; 2St George’s Hospital, 
London, UK
Breast Cancer Research 2010, 12(Suppl 3):P29 (doi: 10.1186/bcr2682)
Introduction: Our protocol for assessment of women with screen-detected 
malignancy was changed to include bilateral whole breast and axillary 
ultrasound (BBUS) following a prospective study that confi  rmed the benefi  t 
of this in 2002 [1]. This audit assesses the impact of introducing this change.
Methods Biopsy results for all women with screen-detected cancer diagnosed 
between April 2003 and March 2009 were reviewed to identify cases where 
multiple biopsies had been performed. The reason for additional biopsy and 
subsequent management were recorded. The data were compared with 
control data (2001) obtained prior to the introduction of the protocol, and 
with national outcome data for screen-detected cancer.
Results A total of 199,307 women were screened during the audit period, 
and 1,700 women were diagnosed with breast cancer. Table 1 demonstrates 
the fi  ndings for women diagnosed with cancer who had additional biopsies, 
Breast Cancer Research 2010, Volume 12 Suppl 3
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has a repeat operation rate of 18% for non-invasive disease and 16% for 
invasive disease compared with national averages of 28% for non-invasive 
and 23% for invasive cancer [2].
Conclusions Additional cancers and axillary node metastases were detected 
as a result of introducing a policy of proactive assessment of disease extent. 
The unit has a favourable rate of re-operations compared with national data.
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Introduction B3 (benign with uncertain malignant potential) lesions such 
as atypias and papillary lesions have fi  nal surgical outcome of malignancy 
in about 20% of vacuum-assisted and 45% of image-guided core biopsies. 
We examine the benefi  ts of undertaking a second image-guided biopsy in 
these cases.
Methods A retrospective study of all B3 lesions diagnosed between January 
2008 and December 2009 at the North London Breast Screening Service.
Results Out of 235 biopsies in 167 women over a 2-year period, there were 
191 B3 outcomes of which 59 had a fi   nal malignant outcome (30.8%). 
Following MDT discussion, 60/191 B3 lesions were subjected to a second 
biopsy (25.5%) and one lesion a third biopsy. These yielded a malignant 
diagnosis in 11 (18.3%) cases. Lesions successfully upgraded to malignancy 
included three microcalcifi  cation (MCC), three masses, three masses with 
MCC and one cyst with solid elements. Cancers diagnosed on second 
biopsies were one invasive ductal, one invasive papillary carcinoma and nine 
ductal carcinoma in situ (DCIS). All second biopsies were performed using a 
vacuum device with the initial biopsy method being 14G core biopsy in eight 
cases and vacuum-assisted in three cases. Second biopsies were therefore 
equally useful in upgrading MCC and masses and especially useful for DCIS.
Conclusions Second-time image-guided biopsies can successfully yield 
a defi   nitive malignant diagnosis in B3 lesions (18.3%) and thus enable 
therapeutic rather than diagnostic surgery to be undertaken. Second 
biopsies are equally useful in the management of MCC, masses and masses 
with MCC.
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Screening MRI in patients at high risk of breast carcinoma from the 
Manchester family history clinic: our initial 2-year experience
Y Lim, E Hurley, P Riley
University Hospital of South Manchester, UK
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Introduction Studies have shown that the combination of MRI and 
mammography is the most eff  ective screening method for women at high 
risk of carcinoma, resulting in a recommendation from the National Institute 
for Health and Clinical Excellence (NICE) for annual surveillance MRI. The 
purpose of this study is to determine the eff  ectiveness of screening MRI in 
this group.
Methods A retrospective review was performed of all the patients from our 
family history clinic who were referred for breast MRI screening in accordance 
with the NICE guidelines. The study period was from July 2008 to July 2010. 
The recall rate, biopsy rate and outcome were recorded and analysed.
Results A total of 233 scans were performed in 173 patients over the 2-year 
period. Of these, 38 (16.3%) were recalled for a second-look ultrasound scan 
(US). Fourteen of these underwent biopsy (6%). US-guided core biopsy in 
12 patients confi  rmed six cases of invasive ductal carcinoma and six cases 
of benign pathology. Two cases were referred for MR-guided biopsy, where 
one case was shown to be DCIS and the other was shown to be fi  brocystic 
change. Overall, there were seven cases (3% of scans or 4% of patients) of 
malignancy that were all mammographically occult. Nine of the cases (3.9%) 
had early repeat MRI scans that were unremarkable. Recall for assessment 
and cancer detection rates were comparable with published data.
Conclusions This study has shown that MRI is an eff  ective screening tool in 
the surveillance of women at high risk of breast carcinoma.
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Current clinical use of the [18F]FDG PET/CT in breast cancer patients: an 
audit of local referral patterns
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Breast Cancer Research 2010, 12(Suppl 3):P33 (doi: 10.1186/bcr2686)
Introduction [18F]FDG PET/CT scanning has been shown to be an established, 
accurate method of detecting many primary and metastatic tumours. 
However, widespread use of PET/CT scanning in the UK remains generally 
limited, as it is expensive and restricted to a few tertiary centres. Cheltenham 
General Hospital receives referrals for patients from across the southwest of 
England and Wales for [18F]FDG PET/CT. We looked at the referral patterns of 
patients with breast cancer to see whether they refl  ected current indications 
for [18F]FDG PET/CT and to see whether the fi  ndings impacted on clinical 
decision-making.
Methods Ninety-fi  ve  [18F]FDG PET/CT scans from 2006 to 2010 were 
requested for breast cancer patients. The indications and results of these 
were recorded and analysed.
Results The following indications were found – staging scans in patients 
with locoregional disease: 22%; equivocal radiology: 17%; specifi  c concern of 
recurrent disease: 17%; diagnostic/therapeutic confl  ict with second primary: 
15%; staging of locally advanced disease: 11%; response to endocrine or 
chemotherapy: 9%; stability/speed of progression of metastatic disease: 
8%. On reviewing clinical records/follow-up, the results of [18F]FDG PET/
CT in many circumstances gave information about metastatic disease in 
locoregional recurrence, resolved issues surrounding equivocal radiology 
and ensured that patients with second operable cancers were not subjected 
to major surgery only to succumb to their breast metastasis.
Conclusions [18F]FDG PET/CT can give valuable information in patients with 
breast cancer, particularly in scenarios with equivocal fi  ndings on other 
imaging and regarding disease progression. The technique often contributed 
to management decisions in complex cases.
Table 1 (abstract P29)
 Audit  (n = 1,700)  Control (n = 105)
Additional biopsy  318 (19%)  6 (5.7%)
Additional biopsy shows cancer  160 (9.4%)  6 (5.7%)
Contralateral biopsies   47 (2.8%)  0 (0%)
Bilateral cancer   22 (1.3%)  0 (0%)
FNAC of axillary node   150 (8.8%)  0 (0%)
FNAC shows nodal metastases   55 (3.2%)  0 (0%)
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Incident cancer cases: what can we learn from the previous screening 
round?
JM Scarth, G Markham, S Kulaveerasingam
North London Breast Screening Unit, London, UK
Breast Cancer Research 2010, 12(Suppl 3):P34 (doi: 10.1186/bcr2687)
Methods A retrospective analysis of all incident cancers with their previous 
screening round mammograms diagnosed between April 2006 and March 
2008 at the North London Breast Screening unit was performed.
Results Two hundred and forty cancers were reviewed. In 187 cases (77.9%) 
the previous round mammograms were normal (group A), in 53 cases 
(22.1%) an abnormality was detected (group B). Of these, fi  ve (9.4%) were 
classifi  ed as normal/benign, 40 (75.5%) were uncertain and eight (15.1%) 
were suspicious. There was no signifi  cant diff  erence in the size of the lesions 
between the two groups; there was, however, a signifi  cant increase in size 
in the lesions in group B on the subsequent mammograms (P <0.0001). Of 
the lesions in group B, 25 (47%) of the cases had microcalcifi  cations only on 
the previous mammograms; this is higher than previously published data 
of 27% and 17% [1,2] with all of these cases being subsequently diagnosed 
as either DCIS or IDC. Group A had less non-invasive (53, 29%) and grade 3 
tumours (26, 20%) compared with group B (non-invasive = 18, 34%; grade 3 = 
9, 29%) and more grade 1 tumours (51, 39% vs. 8, 26%) with a similar amount 
of grade 2 tumours between the groups (41% and 45%).
Conclusions In 22% of incident cancer cases an abnormality is present on the 
previous screening round mammogram, and the most frequently overlooked 
lesions are microcalcifi  cations.
References
1. Maxwell  AJ,  et al.: Breast 2001, 10:392-398.
2. O’Flynn  EAM,  et al.: Breast Cancer Res 2009, 11(Suppl 2):P8.
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biopsy: a worthwhile exercise?
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Introduction There has been increasing interest in the use of vacuum-
assisted core biopsy (VACB) over the past two decades. There remains some 
uncertainty about its role in the presence of cytological or architectural 
atypia on needle core biopsy (NCB). We have recently been off  ering VACB 
for selected B3 cases with atypia. MDT discussion, where technical suitability 
and potential value of VACB is debated, is used to select appropriate cases.
Methods A retrospective case review of all B3 lesions diagnosed at NCB 
between 1 March 2008 and 1 March 2010.
Results A total of 166 B3 lesions were diagnosed: 123 underwent surgical 
biopsy, of which 30 were malignant (eight invasive, 22 non invasive), 10 had 
LCIS and 83 were benign. Forty-three B3 lesions underwent VACB: 18/43 
lesions had shown atypia at NCB and following VACB, seven were upgraded 
to DCIS, three were downgraded to B2, six remained as B3 with atypia 
(5/6 had surgery – three malignant, two benign). VACB failed in two cases. 
Twenty-fi  ve out of 43 cases had shown no atypia at NCB. One out of 25 was 
upgraded to B4 on VACB, but no malignancy was seen at surgery. Twenty-
four out of 25 cases were downgraded to B2.
Conclusions  Our results show a potential benefi   t of this technique in 
selected cases. We were able to upgrade 39% of B3 lesions with atypia, 
thereby allowing immediate defi   nitive surgery. We were able to avoid 
surgical excision in 3/18 (17%) of B3 lesions with atypia.
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Introduction Gynaecomastia is a benign enlargement of male breast tissue 
that has no proven excess risk of breast cancer. Clinical evaluation is required 
to exclude breast cancer, but the role of imaging in the male breast is unclear. 
Our aim was to determine practice in other units, review literature and 
formulate informed and realistic departmental guidelines.
Methods A questionnaire was created, and copies placed on delegates’ seats. 
Descriptive statistics applied.
Results Of approximately 160 delegates, 90 questionnaires were returned 
from at least 58 diff  erent units. Delegates reported (estimated) greater than 
864.75 years collective experience, each performing (on average) 4.3 male 
breast assessments per month. Sixty-fi  ve per cent (58/89) of delegates that 
responded reported routine imaging in clinically typical gynaecomastia, 
rising to 89% (79/89) in clinically typical unilateral gynaecomastia. However, 
78% (68/87) of responding delegates agreed with the statement ‘Imaging is 
not necessary in cases of clinically typical gynaecomastia’. Three delegates 
reported experiencing a case of ultrasonically typical gynaecomastia that 
subsequently proved to be breast cancer. Imaging protocol and biopsy 
practice varied greatly between units. Delegates volunteered concerns that 
the NHS breast service is inequitable between males and females, and that 
guidelines were needed to rationalise imaging.
Conclusions  Based upon questionnaire fi   ndings and literature review, 
guidelines have been now been drawn up in our unit. There is great variation 
evident in UK gynaecomastia imaging practice. National discussion and 
agreement on evidence-based guidelines could help rationalize use of 
precious NHS resources and reduce imaging of this benign condition.
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separating calcifi  ed and noncalcifi  ed core biopsies
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Introduction Suspicious microcalcifi   cation is investigated by vacuum-
assisted core biopsy. Many patients, in whom malignancy is diagnosed, go 
on to have breast-conserving surgery where positive resection margins 
require re-operation. The aim of this study was to determine whether there is 
an increased risk of positive margins when malignancy is identifi  ed in cores 
without microcalcifi  cation.
Methods In this institute, core biopsy samples are separated into those 
containing calcifi   cation and those not. Sixty-eight consecutive patients 
undergoing breast-conserving surgery were selected. From the histology 
report, the presence of malignancy in each group of cores was recorded. 
The adequacy of margins following the local excision and the need for re-
operation was then analysed.
Results Sixty-eight patients were included in the study. The mean age at 
diagnosis was 56.7 (range 40 to 77). All 68 patients had malignancy in the 
cores containing calcifi  cation. Twenty-three (34%) patients had malignancy 
in these cores alone and nine (39%) of these patients required further 
surgery. Forty-fi  ve patients had malignancy in both of the sets of cores, 24 
(53%) required further surgery for inadequate margins. Although there is a 
diff  erence between the re-operation rate, this is not statistically signifi  cant 
(P = 0.3124, Fisher’s exact test).
Conclusions Malignancy is commonly diagnosed in cores that do not 
contain microcalcifi  cation. Although there appears to be a higher rate of 
inadequate margins in this group (53% vs. 39%), in this study the diff  erence 
was not statistically signifi  cant. Following the fi  ndings of this initial study, we 
are now increasing the sample size of the group.
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function to improve calcifi  cation visualisation
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Introduction Mammographic calcifi  cation may be the only sign of breast 
malignancy often requiring diagnostic biopsy. If visible, this calcifi  cation 
may be biopsied using ultrasound guidance or using X-ray guidance if 
not. Ultrasound biopsy is quicker, cheaper and more comfortable for the 
patient. Any technique that improves ultrasound calcifi  cation visualisation 
is desirable. MicroPure™ (Toshiba Medical Systems Corporation, Otawara, 
Japan) is a new ultrasound processing technology designed to achieve this.
Methods  We prospectively audited our experience of calcifi  cation 
detection with B-mode ultrasound and MicroPure™ between April and July 
2010. Twenty-fi   ve women presenting with a dominant mammographic 
abnormality of calcifi   cation were studied. Targeted imaging with both 
techniques was performed with a Toshiba Aplio™ XG ultrasound machine 
using a 12 MHz linear probe. Technical support to optimise imaging was 
provided during our audit by Toshiba. We recorded ultrasound visibility with 
these two techniques and histological diagnosis.
Results Of 24 screening and one symptomatic woman examined, 11 (44%) 
were diagnosed with breast malignancy (six invasive cancers, four DCIS, one 
LCIS), and 14 (56%) were benign. Overall four (16%) (three malignant and 
one benign) calcifi  cations were visualised by ultrasound. All were detectable 
using both B-mode and MicroPure™. Subjectively all four were felt to be 
more conspicuous using B-mode than MicroPure™.
Conclusions  Our initial experience has demonstrated MicroPure™ to be 
no better at detecting benign or malignant mammographic calcifi  cation 
than B-mode ultrasound. MicroPure™ would only be useful if it detects 
calcifi   cations that are not visualised with B-mode ultrasound therefore 
reducing X-ray-guided biopsies.
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Introduction  Triple-negative breast cancer (TNBC) cases comprise 
approximately 15% of newly diagnosed breast cancers and are associated 
with poor prognosis and limited treatment options. In this retrospective 
study from South Wales, 81 patients with breast cancer found to be ER, PR 
and HER2 negative were reviewed to determine whether there are common 
imaging and pathological fi  ndings.
Methods Patients identifi  ed from pathological databases at two hospitals 
included symptomatic and screening cases. Clinical records were reviewed to 
determine age at diagnosis, family history and clinical fi  ndings; pathological 
reports to identify size, grade, type and nodal status; and imaging studies to 
determine breast density, lesion type, classifi  cation and size.
Results Eighty per cent of patients were aged over 50 years (range 50 to 
89 years). Nineteen per cent reported a family history. Eighty-nine per cent 
were grade 3 tumours, 89% were ductal type of which 30% had associated 
DCIS. The majority were large tumours (78% over 20 mm). Fifty-two per 
cent were node positive (20% had more than four nodes positive). Thirty-
nine per cent had associated vascular invasion. Calcifi  cation was a dominant 
mammographic feature (37%), 28% had well-defi  ned masses.
Conclusions  Previous studies have found well-defi   ned masses to be a 
dominant imaging feature but this study has found malignant calcifi  cation to 
be more common. The tumours were mainly large and frequently associated 
with vascular invasion, possibly contributing to the poor prognosis despite 
being node negative in nearly one-half of the cases. There appears to be an 
association with family history and to be common in the over 50s, contrary 
to current thinking. A national prospectively collected database TNBC could 
aid understanding of this group.
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Introduction During the changeover from analogue to digital screening in 
the UK, reassurance is needed to confi  rm that the outcomes with digital are 
equal to or better than analogue screening.
Methods  Warwickshire, Solihull & Coventry Breast Screening Service 
commenced the phased conversion to digital screening in 2005, with a single 
digital machine on one of three mobiles. This retrospective study compares 
the screening outcomes of 138,173 women aged between 49 and 70 years 
screened on analogue or digital imaging between April 2005 and March 
2009 inclusive. Approximately one-third of these were screened using digital, 
the remainder on analogue.
Results The results show no diff  erence in the rates of screen-detected cancer 
in prevalent or incident groups between analogue and digital, and rates were 
stable with time. Similar proportions of invasive and non-invasive cancers 
were detected in both groups and tumour size was not signifi  cantly diff  erent. 
No signifi  cant increase in cancer detection in younger compared with older 
women was seen in the digital group, and digital did not diagnose a higher 
proportion of lobular cancers. No diff  erence in interval cancer rates between 
the two methods of screening was seen. On radiological subclassifi  cation of 
interval cancers into normal/benign, uncertain and suspicious, signifi  cantly 
fewer interval cancers were classifi  ed as uncertain in the digital than the 
analogue screening group. See Table 1.
Conclusions  These results are reassuring that digital diagnoses similar 
cancers to analogue screening, and suggest that digital may allow more 
defi  nitive interval cancer classifi  cation.
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scheme
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Introduction All UK screening personnel are invited to take part annually 
in the PERFORMS self-assessment scheme where they make several 
judgements about series of challenging recent screening cases. As part of 
this process they assess the density of each case. Density is a factor known 
to be associated with a greater risk of developing breast cancer and thus 
accurate density judgements may well presage the facility to proff  er 
improved follow-up for individual women. The present study examines the 
degree of variability amongst fi  lm reader estimates of breast density on a 
large number of cases.
Methods Data were examined from the most recent 2 years of the PERFORMS 
scheme where breast density estimates were made for each case examined 
using a three-point rating scale of fatty, mixed density, and dense. These data 
comprised information from 444 individuals (mainly consultant radiologists, 
advanced practitioners and breast physicians) who had all examined the 
same 240 diffi   cult cases.
Results  The inter-rater reliability, corrected for chance agreements, was 
assessed using kappa. Overall, the degree of agreement across cases 
on breast density category was signifi  cantly greater than no agreement 
(P <0.0001). However, only a moderate degree of inter-rater reliability was 
Table 1 (abstract P41)
 Analogue  Digital
  n  % (95% CI)  n  % (95% CI)
Normal/benign  97  73.5% (66.0 to 81.0%)  72  85.7% (7.02 to 93.2%)
Uncertain  20  15.2% (9.0 to 21.3%)  3  3.6% (–0.4 to 7.5%)
Suspicious  15  11.4% (5.9 to 16.8%)  9  10.7% (4.1 to 17.3%)
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S11exhibited, κ = 0.470. There were signifi  cant diff  erences between the levels of 
agreement amongst the ratings of the radiologists, advanced practitioners 
and others (all P <0.05).
Conclusions  The low agreement rates between participants for density 
ratings were surprising. That there were diff  erences between the occupa-
tional groupings may refl  ect breast screening experience.
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Introduction This literature review examines evidence relating to needle 
biopsy of the breast and the potential for later tumour cell migration into 
adjacent tissues.
Methods A literature search was undertaken, using Medline, Embase and the 
Cochrane Library.
Results The results were analysed by the following: (1) Histological evidence 
of spread (seven papers addressing this were scrutinised; number of 
patients reviewed was 1,046). Tumour cell displacement occurs in about 
one-third of patients, the majority do not survive displacement. Vacuum 
biopsy techniques may reduce seeding potential. (2) Clinical evidence 
of recurrent disease (nine papers were scrutinised; number of patients 
reviewed was 1,575). Sporadic reports of tumour recurrence suspected to be 
a consequence of a biopsy procedure are described. Care to excise the site of 
needle biopsy is advised by some, especially if outside the radiotherapy fi  eld. 
(3) Likelihood of seeding dependent upon tumour type (three papers were 
scrutinised; number of patients reviewed was 258). There is limited evidence 
to suggest lobular carcinoma is less likely to seed than ductal.
Conclusions There is histological evidence of seeding of tumour cells from 
the primary neoplastic site into adjacent breast tissue, following biopsy. 
However, clinical recurrence at the site of a needle biopsy is uncommon. 
This event may be lessened by use of vacuum biopsy techniques. The site of 
needle biopsy should be considered at the time of surgery.
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A Ramakrishnan, I Haigh, J Liston, BJG Dall, N Sharma
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Introduction The prevalent round recall rate is higher than the incident recall 
rate. Implementation of age extension will lead to two prevalent rounds and 
with this increased clinical and fi  nancial pressure on screening units. Any 
processes that help reduce the recall rate will be of benefi  t to screening units.
Methods Retrospective data were collected from April 2008 to March 2009 
of prevalent round ladies recalled to assessment clinics. The data recorded 
included reason for recall, imaging fi  ndings and needle test results.
Results A total of 7,627 women were invited for screening in April 2008 to 
March 2009, of which 5,341 attended. Four hundred and eighty-one ladies 
were recalled to assessment; 451/481 of the packets available were reviewed. 
Forty cancers were identifi  ed in 39 patients. All cases of malignancy were 
coded as RU, RS or RM at the time of fi  lm reading. Thirty-two patients were 
recalled for both sides, four patients recalled for two lesions within the same 
breast. Nineteen patients were clinical recalls (BA). All solitary RB masses 
thought to be benign at the time of fi  lm reading proved to be benign (91/215 
masses). Ten cases recalled for bilateral RB masses were benign. Thirty-six out 
of 140 asymmetries thought to be benign at the time of fi  lm reading were 
benign.
Conclusions The recall rate may be reduced in the prevalent round by not 
recalling solitary RB masses, bilateral RB masses, and asymmetry that appears 
physiological/benign on two views. In this unit this would have reduced the 
recall rate without adversely aff  ecting the cancer detection rate.
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Breast histoscanning: the development of a novel technique to improve 
tissue characterization during breast ultrasound
LS Wilkinson, C Coleman, CM Pagliari, P Skippage, V Thomas, R Given-Wilson
St George’s Healthcare NHS Trust, London, UK
Breast Cancer Research 2010, 12(Suppl 3):P46 (doi: 10.1186/bcr2699)
Introduction Imaging alone cannot reliably distinguish benign/malignant 
breast disease or assess the extent of cancer. This study assesses the feasibility 
of using additional information obtained at US (BHS) to aid diagnosis and 
preoperative assessment.
Methods 3D US scans at 8 MHz, 12 MHz, 15 MHz were obtained of breast 
tissue in normal volunteers in two planes and with/without harmonics. Five 
volumes of sagittal scans at 8 MHz from three individuals were used to identify 
normal characteristics and defi  ne the baseline. The 3D volume was divided 
into voxels (0.1 x 2 x 1.5 mm) and raw data from each voxel were analysed by 
applying linear and nonlinear classifi  ers to assess 29 statistical characteristics 
(BHS). The training dataset contained 300,000 voxels. After training, the 
classifi  er’s output showed 3% error on both normal and abnormal tissue. The 
algorithm was tested on 32 further volumes representing 6,000,000 voxels of 
normal and abnormal tissue from 20 individuals. Abnormal tissue included 
various biopsy-proven lesions: malignancy (six), papilloma (one), hamartoma 
(one), fi   broadenoma (two), cyst (two), fi   brosis (one). Subclassifi  ers  were 
developed to distinguish between cancer and benign voxels.
Results In 17 normal testing volumes, 3% of isolated voxels were classifi  ed as 
abnormal. In 15 abnormal testing volumes, the subclassifi  ers diff  erentiated 
between malignant and benign tissue. BHS in benign tissue showed <1% 
abnormal voxels in cyst, hamartoma, papilloma and benign fi  brosis. The 
fi  broadenomas diff  ered showing <5% and <24% abnormal voxels. Abnormal 
voxels in cancers increased with the volume of cancer at pathology.
Conclusions  Histoscanning reliably discriminated normal from abnormal 
tissue and could distinguish between benign and malignant lesions.
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at 3T
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Introduction In vivo detectability of a signal (tCho) from choline containing 
molecules at ~3.2 ppm by MR spectroscopy (MRS) can be useful as a 
biomarker for malignancy. tCho has also been observed in benign, normal, 
and lactating breast, therefore quantitation is vital. The aim is to assess 
whether tCho detectability can diff  erentiate between benign and malignant 
breast disease and to implement internal water-referenced choline 
quantitation at 3T.
Methods Women with histologically confi  rmed breast cancer or suspicious 
features were identifi  ed either at MDT or following referral for clinical breast 
MRI and recruited following informed consent. Studies were performed 
on 3T Philips Achieva (the Netherlands). Contrast-enhanced MRI localised 
the region for point-resolved spectroscopy (PRESS) evaluation. Spectral 
processing was performed with jMRUI. The choline concentration was 
determined using the unsuppressed intravoxel water resonance as a 
reference. tCho detectability and choline concentration were correlated with 
known pathological information. Results were analysed by JKPB.
Results  Nine participants (age range, 38 to 73 years) were successfully 
examined. tCho was detected at ~3.2 ppm in four of nine lesions (lesion size, 
0.8 to 7.0 cm; mean, 3.0 cm), providing a sensitivity and specifi  city of 67% and 
100%, respectively. The two quantitative values of 2.13 and 5.59 mmol/kg are 
consistent with previously reported fi  ndings.
Conclusions MRS is a non-invasive and non-ionising means of analysing 
lesion metabolism as an adjunct to clinical MRI. Whilst potentially useful 
for diff   erentiating between benign and malignant breast diseases, 
implementation is challenging. Using clinical 3T systems, internal water 
referencing can successfully quantify choline in patients with breast cancer.
Breast Cancer Research 2010, Volume 12 Suppl 3
http://breast-cancer-research.com/supplements/12/S3
S12P48
Benefi  ts of CT-angiography localisation in the surgical planning of deep 
inferior epigastric perforator fl  ap breast reconstruction
NC Chhaya1, P Sarbeng1, S Stuart1, F Angullia2, A Mosahebi2, A Malhotra1
1Department of Radiology, Royal Free Hospital, London, UK; 2Department of Plastic 
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Introduction The aim of breast reconstruction in the postmastectomy cancer 
patient is to restore breast contour and dimensions whilst minimising the 
cosmetic impact. The deep inferior epigastric perforator (DIEP)-fl   ap is a 
complex but state-of-the-art procedure that provides a durable and natural 
result. It is rapidly becoming the preferred choice at many institutions, 
including our regional plastic surgery unit. In achieving superior cosmesis 
without sacrifi   cing abdominal wall musculature, a successful DIEP-fl  ap 
requires painstaking and time-consuming microdissection of the inferior 
epigastric artery perforators. This relies on a high level of surgical expertise 
and results in prolonged anaesthetic times. As greater volumes of breast 
reconstructive surgery are performed, there will be increasing requirements 
for such preoperative imaging. We describe the required optimisation of CTA 
protocols to obtain the pertinent information and demonstrate how best to 
convey this complex information to our surgical colleagues.
Methods Since 2009 we have provided CT-angiography in the preoperative 
planning for DIEP-fl  ap breast reconstruction. We explored the implications of 
CT-angiography to optimise localisation of arterial perforators and identifi  ed 
the benefi  ts of this imaging-guided approach.
Results  A total of 60 female patients have benefi  tted from CTA-guided 
perforator localisation, providing valuable procedural-planning information 
to our surgical colleagues. We have shown benefi  ts in terms of markedly 
shorter operative duration with consequently reduced hospital stays and 
morbidity. Two patients had unsuspected metastatic disease identifi  ed, 
precluding reconstructive surgery.
Conclusions An imaging-guided approach optimises preoperative planning. 
Accurate identifi  cation of arterial perforators enables targeted intraoperative 
localisation. This results in decreased operative time and patient morbidity, 
providing benefi  ts for the cost of healthcare provision.
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Introduction Studies estimate that 10 to 32% of breast cancers are over-
looked in mammograms. One of the important causes of interval breast 
cancer is fatigue and loss of concentration. The likelihood of fatigue increases 
with the duration of a reporting session and errors are more likely to occur 
towards the end of the session. The purpose of this talk is to address the lack 
of awareness of the issues that drive reporting performance.
Methods A retrospective study was carried out on interval breast cancers 
from a 2-year period. This identifi  ed 90 histopathologically proven interval 
breast cancers. Each interval cancer mammogram was reviewed by two 
blinded consultant radiologists and placed into one of three categories on 
retrospective radiological review: Category 1: normal; Category 2: uncertain; 
Category 3: suspicious. Each case was then analysed further to correlate the 
interval categories with their position on the mammography roller viewer.
Results Of the 90 interval breast cancers, 59 (66%) were Category 1, 14 (16%) 
were Category 2 and 17 (18%) were Category 3. Statistical analyses with 
one-way ANOVA test revealed the presence of clinical signifi  cance between 
Category 3 cases and their position in the roller viewer (P <0.021).
Conclusions Fatigue is identifi  ed as an important factor responsible for 
missing breast cancer. Aside from making changes in double-reporting 
techniques, human performance factors such as nutrition, rest, behaviour 
prior to reporting and environment have to be considered. A national 
programme has to be implemented to facilitate a plan to raise awareness of 
these factors in the NHS culture.
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Benign solitary breast masses in the prevalent screening round: do they 
contribute to a high recall rate?
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Background The Breast Test Wales prevalent round recall rate between 2003 
and 2006 was 9.07% (above the NHSBSP target of 7%) and remains high. 
This study was based on the hypothesis that recall of benign solitary masses 
might be a major contributor to this as no prior imaging is available. 
Methods Prospectively collected data from Breast Test Wales (South East 
Wales) identifi  ed all prevalent screens in a 3-year cycle recalled for a benign 
mass lesion confi  rmed by core biopsy. All women attended a subsequent 
screen and remained free of cancer. Mammograms were retrospectively 
reviewed and the lesions were re-evaluated by applying criteria typical of 
a benign mass.
Results A total of 2,322 women following a prevalent screen were recalled; 
2,069 were returned to routine recall without biopsy (cysts are included in 
this group), 186 were diagnosed with cancer and 105 had a benign biopsy 
where mammography had been considered benign or probably benign. 
The benign to malignant biopsy ratio was 1:1.8. A total 46.6% (n = 49) 
lesions on retrospective review of mammography showed typical benign 
characteristics. Dense breast composition and overlying glandular tissue 
were noted to correlate with higher rates of retrospectively indicated recall.
Conclusions Stricter adherence to applying classifi  cation of benign solitary 
lesions could reduce the recall rate and decrease the psychological distress 
for these women without adversely compromising the cancer detection rate. 
The impact on the overall recall rate would be small but would signifi  cantly 
improve the benign to malignant biopsy ratio. The issue of breast density 
and overlying tissue may be resolved with the advent of digital applications 
such as tomosynthesis.
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Introduction  Around 5% of breast cancers can be attributed to gene 
mutations. NICE guidelines have recently advocated the use of MRI screening 
in high-risk young women. We have retrospectively audited our unit’s 
experience in this fi  eld.
Methods All eligible women were identifi  ed from the family history database. 
Notes, imaging and pathology were reviewed.
Results One hundred and thirty-three breast MRI scans were performed 
on 91 women with a high-risk family history between 2007 and 2010. 
Sixteen women were recalled for assessment (one woman was recalled 
twice). The total recall rate was 12.7%. Of the recalled patients, four had 
normal ultrasound (US) and follow-up imaging has remained unchanged. 
Thirteen patients had corresponding US-detected abnormalities. Twelve 
were biopsied, the other was a normal intramammary lymph node. Eight of 
the biopsies were benign (benign core biopsy rate 6%). Four biopsies were 
malignant (age range of women 35 to 45), giving a cancer detection rate 
of 3%. Three of these were solitary lesions (8 mm, 11 mm and 16 mm). One 
patient had multifocal malignancy, the largest single lesion being 16 mm. 
All were node-negative ductal carcinoma. Two patients were oestrogen 
receptor-positive, all were herceptin receptor-negative. Only the extensive 
malignant change could be seen on conventional mammography.
Conclusions We suggest that MRI screening is benefi  cial in these patients, 
and although our recall rate lies a little above what is to be recommended 
by the NHSBSP (7 to 10%) we feel this can be attributed to the steep learning 
curve that introducing a new screening technique to a service invariably 
brings.
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measurement of malignant breast masses with operative histology
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Introduction  Preoperative assessment of breast cancer patients is by 
physical examination, mammography and ultrasound. Mammography 
and ultrasound measurements inform treatment regimes and prognostic 
estimates. Our aim was to determine the accuracy of imaging measurement 
of malignant breast masses in our Trust.
Methods  Screening and symptomatic women with breast cancer who 
had surgery between October 2008 and May 2009 were identifi  ed from 
multidisciplinary team records. The largest dimension of abnormal tissue/
breast mass on any projection/probe orientation was documented for 
mammography and/or ultrasound. Measurements were compared with the 
largest tumour dimension on fi  nal histological analysis of excised tumour.
Results Records were available for 100 patients with invasive breast cancer 
(66% (66/100) invasive without DCIS, 34% (34/100) invasive with DCIS). 
Overall size of the malignancy measured at both mammography and 
ultrasound correlated with histological tumour size (r = 0.54 and r = 0.56, 
respectively). This correlation was less high for overall size of malignancy 
when associated with DCIS. Mammography with DCIS (r = 0.37) versus 
mammography without DCIS (r = 0.77); ultrasound with DCIS (r = 0.52) 
versus r = 0.68 for invasive cancers without DCIS. Multiple regression analysis 
showed that the combination of mammogram and ultrasound is an eff  ective 
means of estimating size of malignancy in the presence of a mass (r2 = 0.67).
Conclusions  The combination of mammography and ultrasound is an 
eff  ective means of predicting tumour size; it is more accurate for tumours 
without DCIS. There is a tendency towards size underestimation, more so for 
ultrasound than mammography.
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What is involved in a comprehensive breast MRI service? Implications for 
service provision
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Introduction  MRI as an adjunct to triple assessment is well established, 
but often identifi   es additional lesions within the breast necessitating 
further characterisation. This study addresses the additional investigations 
generated by MRI.
Methods A retrospective review of the MRI database between 2006 and 
2009 identifying patients requiring investigations post MRI.
Results Over 4 years, 1,119 MRIs were performed on 717 patients, with 102 
recalled for second-look ultrasound. Three patients were lost to follow-up. A 
total 124 incidental lesions were identifi  ed on MRI. Ultrasound identifi  ed 68 
lesions, with defi  nitive diagnosis following core biopsy/FNAC (62), surgery 
(two) core biopsy + repeat MRI (one) and MRI biopsy (three). Twenty-two 
lesions not identifi   ed by USS were assessed with X-ray-guided biopsy 
(two), MRI biopsy (13), interval MRI (fi  ve) or surgery (two). Nineteen MRI 
lesions following normal ultrasound had routine follow-up. Fifteen lesions 
(12 patients) did not have follow-up USS, as recommended following 
MDT discussion. Sixty lesions (44 patients) were malignant; MRI identifi  ed 
a primary in four patients presenting with lymphadenopathy and in 39 
patients identifi  ed additional foci that changed management. Malignant 
lesions were identifi  ed on US biopsy/FNAC (38), X-ray-guided biopsy (one), 
MRI biopsy (seven) and surgery (14).
Conclusions  MRI identifi  es additional foci in 14% of patients. Malignant 
lesions will be identifi  ed in 43% of patients recalled. Comparison with 2005 
data identifi  es a decreased recall rate and an increased cancer detection rate. 
Fifty per cent of additional lesions identifi  ed by MRI are malignant, of which 
77% were confi  rmed preoperatively. Provision of a comprehensive breast 
MRI service must consider the resources needed to deliver the additional 
diagnostic investigations required.
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Introduction We audited pain from ultrasound-guided core biopsies (CB) for 
routine service quality monitoring, to provide baseline data against which to 
compare new techniques, and to help us develop methodological expertise 
in pain assessment. Although there is no standard against which to audit CB 
pain, published comparators are available.
Methods Two self-report pain scales were administered to 64 female patients 
immediately after ultrasound-guided 14G CB under local anaesthesia. 
Although we aimed for consecutive patients, some were de-selected by staff   
on grounds of apparently high levels of cancer anxiety. The scales were a 
100 mm visual analogue scale (VAS) and a four-category verbal rating scale 
(VRS) – None, Mild, Moderate, Severe. Responses were anonymous and no 
attempt was made to collect data on relevant variables. VAS scores were 
compared between VRS categories using the Mann–Whitney U test.
Results Sixty questionnaires were adequate for analysis. VAS scores were not 
normally distributed and ranged from 0 to 80, median 7.5, interquartile range 
15 (mean 15.6 ± SD 22.3). The paired VAS and VRS results correlated well and 
the median VAS scores for the diff  erent VRS categories demonstrated clear 
distinctions between categories (P <0.001).
Conclusions  The correlation between VAS scores and VRS categories is 
evidence supporting the validity of the scales. Our overall mean VAS score 
was lower than the most comparable values in the literature. We will use our 
audit to illustrate a discussion of the principles, including scale selection, and 
the pitfalls of pain assessment in relation to existing relevant literature.
P59
Educational abstract
Educational abstract not submitted for online publication.
Breast Cancer Research 2010, 12(Suppl 3):P59 (doi: 10.1186/bcr2712)
P60
Breast cancer screening in the over 70s
D Eddy1, L Edwards2, K Gower-Thomas2
1Welsh School of Medicine, Cardiff  , UK; 2Breast Test Wales, Cardiff  , UK
Breast Cancer Research 2010, 12(Suppl 3):P60 (doi: 10.1186/bcr2713)
Introduction Routine invitation for breast screening currently ceases in Wales 
over the age of 70 despite the incidence of breast cancer remaining high in 
this group. Attendance for screening aged over 70 is low compared with the 
invited population, often attributed to lack of awareness of eligibility and 
how to access screening. If screening is to be extended, the motivation to 
attend and outcomes need to be understood.
Methods This audit of prospectively collected data from Breast Test Wales 
Screening (South East Wales) identifi   ed all women over 70 years who 
attended. In those where cancers were detected, age, pathological data, 
previous screening history, family history, clinically palpability and breast 
symptoms were recorded.
Results A total of 5,736 women attended aged 71 to 92 years in a 3-year 
screening round (1 April 2006 to 31 March 2009) with numbers attending 
decreasing with higher age. In total, 295 (5.1%) were recalled to assessment 
and 81 (1.4%) were diagnosed with cancer. A total of 61.5% of the cancers 
were grade 2, 77% <20 mm and 84% node-negative. The majority had an 
excellent or good Nottingham Prognostic Index, mirroring national data for 
the younger invited population. Of those diagnosed with cancer, 61.6% had 
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55.4% were clinically palpable and of these 49% had themselves noticed a 
change in the breast. 
Conclusions This study indicates that women continue to attend regularly 
after invitation ceases. Clinical concerns and family history awareness may be 
motivators but as cancers detected have good prognostic indices, screening 
this group may be benefi  cial.
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positive margins after breast-conserving surgery?
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Introduction  Twenty-two per cent of women required further surgery 
following breast-conserving surgery (BCS) in the UK in 2008 because of 
involved margins. This study was carried out to see whether it was possible to 
predict the likelihood of this from preoperative information and thus reduce 
the re-excision rate.
Methods Women having BCS following a preoperative diagnosis of invasive 
cancer were identifi  ed from prospectively collected data at Breast Test Wales 
for South East Wales, over a 3-year screening round (2006 to 2009). In cases 
where DCIS was found at or within 2 mm of a margin, preoperative imaging 
was reviewed to look for peripheral calcifi  cation.
Results One hundred and twelve out of 844 women with an invasive tumour 
had involved margins after BCS. Fifty-nine women had DCIS at the margin, of 
which 60% had calcifi  cation within 10 mm of the periphery of the tumour on 
mammographic review and 30% had DCIS as well as invasive cancer on core 
biopsy. The postsurgical pathological size was greater than the mammographic 
size in 79% and greater than the ultrasound size in over 90% of cases. This was 
not signifi  cantly changed on further review of the fi  lms. On mammographic 
review, 12% had dense breasts, 88% being fatty or fatty/glandular.
Conclusions Imaging is underestimating the true size despite background 
breast tissue being fatty. The presence of calcifi  cation on the mammogram 
in such a high number of cases where DCIS is at the margin may be a useful 
predictor, but requires further correlation with the presence of histological 
calcifi  cation on the pathological specimen, which is ongoing.
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Ultrasound of the axilla: analysing nodal cortical thickness
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Introduction  Prognosis in breast cancer is dependent upon axillary 
lymph node status. For breast-conserving surgery, lymph node status can 
be assessed via sentinel lymph node procedures (SLNP) [1]. This can be 
time consuming, however, and it would be useful to identify a subset of 
quantitative nodal features on ultrasound in order to predict metastatic 
involvement and avoid the SLNP. Peer review states that cortical thickness is 
one of the best predictive characteristics [1,2]. We wanted to interrogate our 
own data with a specifi  c focus on this feature.
Methods A retrospective study of 454 patients audited between August 
2007 and October 2009. One hundred and thirty-seven had proven breast 
cancer and underwent axillary node sampling.
Results In 75 cases the cortical thickness was recorded. Comparing with 
sentinel node biopsy or postoperative pathology, the results are as shown 
in Figure 1.
Conclusions The study confi  rms that the nodal cortical thickness correlates 
well with the presence of disease. It is easy to measure and appears to be 
a reliable indicator. Further, the minimum cortical thickness for positivity 
(27 mm) will help us to grade our degree of suspicion in future.
References
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Introduction New guidelines suggest that ultrasound should replace 
mammography as the primary imaging test for 35 to 39 year olds in symptomatic 
outpatient clinics. We currently use clinical examination, clinically guided fi  ne 
needle aspiration and mammograms for women aged 35+ as initial triple 
assessment. We wanted to understand the implications of introducing the 
guidelines, based on our current practice.
Methods We reviewed our workload and cancer detection in symptomatic 35 
to 39 year olds attending breast outpatients in our district general hospital over 
the past 18 months.
Results Mammograms were taken on all symptomatic patients unless pregnant 
or breastfeeding. Seven hundred and fourteen patients had mammograms 
and 442 patients had ultrasound. This was performed on most patients found 
to have clinically palpable lumps, and on anyone with a clinical examination 
graded as uncertain suspicious or malignant, or with abnormal mammograms, 
or with abnormal results on clinically guided needle cytology. Fourteen patients 
were found to have breast cancer. All 14 had ultrasounds graded as uncertain, 
suspicious or malignant, an indication for diagnostic core biopsy. Thirteen cancer 
patients had mammograms. Two were graded as benign and 11 as uncertain or 
worse. Five cancer patients had clinically normal or benign breast examinations, 
including one with a benign mammogram report.
Figure 1 (abstract P63). Cortical thickness in nodal disease.
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out of 13. This supports implementing the guidelines. However, this would 
mean a 38% increase in the number of ultrasounds, 15 extra each month. This 
extra ultrasound capacity may be hard to provide but will be off  set by fewer 
mammograms.
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